Hypothesis

With age, enterochromaffin (EC) cells reprioritize their selective autophagy machinery, favoring degradation of non‑essential cytosolic cargo over ER‑phagy. This shift compromises the turnover of ER‑resident tryptophan hydroxylase‑1 (TPH1), lowering its enzymatic activity and vesicular serotonin (5‑HT) release despite unchanged EC cell numbers. Concomitant age‑related microbiome dysbiosis reduces short‑chain fatty acid (SCFA) production, removing a microbial cue that normally stimulates colonic TPH1 expression. The combined defect produces a "double hit" on colonic 5‑HT signaling that predicts slowed gut motility and constipation in older individuals.

Mechanistic rationale

1. ER‑phagy as a gatekeeper of TPH1 homeostasis – Recent work shows autophagy can selectively target ER membranes during stress, and TPH1 resides in the ER where its folding and activity depend on a healthy luminal environment【2】. If ER‑phagy declines, misfolded TPH1 accumulates, reducing catalytic efficiency.

2. Microbiota‑SCFA boost of TPH1 – Colonic SCFAs (e.g., butyrate) up‑regulate TPH1 transcription via histone deacetylase inhibition【3】. Aging microbiota produce less SCFA, diminishing this transcriptional drive.

3. Substrate hierarchy reprogramming – Nutrient‑sensing pathways (mTORC1, AMPK) that dictate autophagy substrate choice are altered with age, biasing the autophagosome toward mitochondria or lipid droplets while sparing ER【4】. This rewiring creates a selective deficit in ER turnover specifically in secretory cells like ECs.

Testable predictions

• Prediction 1: In aged mouse colons, EC‑cell isolates will show increased LC3‑II association with cytosolic proteins (e.g., GAPDH) but decreased colocalization with ER markers (Calnexin) compared with young mice, detectable by proximity ligation assay or immuno‑EM.
• Prediction 2: Pharmacological enhancement of ER‑phagy (e.g., using the ER‑phagy activator CCPG1 over‑expression or spermidine treatment) will restore TPH1 protein half‑life and colonic 5‑HT secretion in old mice without altering EC cell numbers.
• Prediction 3: Supplementing aged mice with SCFA mixtures (acetate, propionate, butyrate) will rescue TPH1 mRNA levels but not secretion if ER‑phagy remains impaired; only combined ER‑phagy activation + SCFA will fully normalize 5‑HT output and improve colonic transit measured by carcass transit time.
• Prediction 4: Inducing a selective block of ER‑phagy in young EC cells (via CRISPR knock‑out of FAM134B or SEC62) will phenocopy the aged secretion defect, confirming that altered autophagy hierarchy is sufficient to cause functional decline.

Falsifiability

If aged EC cells exhibit unchanged ER‑phagy flux (measured by mCherry‑GFP‑LC3 ER‑phagy reporter) and TPH1 turnover rates comparable to young cells, the hypothesis is falsified. Likewise, if restoring ER‑phagy fails to improve 5‑HT secretion despite verified increase in ER‑phagy markers, the proposed causal link is refuted.

Experimental outline (brief)

1. Mouse cohorts: Young (3 mo) vs. aged (24 mo) C57BL/6J.
2. Isolate EC cells via FACS using Chromogranin‑A‑GFP reporter.
3. Assess autophagy flux: mCherry‑GFP‑LC3 fused to an ER‑targeting signal (Sec61b) imaged by confocal microscopy; quantify red‑only puncta.
4. TPH1 stability: Pulse‑chase with ^35S‑methionine followed by immunoprecipitation.
5. 5‑HT release: Stimulate isolated EC cells with high KCl; measure supernatant serotonin by HPLC.
6. Interventions: Spermidine (5 mM) in drinking water; SCFA cocktail (150 mM total) via gavage; combined treatment.
7. Readouts: Colonic transit time (carmine red assay), stool frequency, immunostaining for TPH1 and serotonin vesicles.
8. Statistical plan: Two‑way ANOVA (age × treatment) with post‑hoc Tukey; n ≥ 8 per group for behavioral assays, n ≥ 4 for cellular assays.

Expected outcome

Aging will show reduced ER‑phagy flux and TPH1 half‑life, lowered basal and stimulated 5‑HT release, and slowed transit. Spermidine will normalize ER‑phagy and TPH1 levels but only partially rescue secretion; SCFA will boost TPH1 mRNA without fixing secretion; combined treatment will restore both secretion and motility to young‑like levels. Failure of any of these patterns would challenge the hierarchy‑centric view of autophagic decline in EC cells.